The profile of cytokine release modulation, with respect to both the specific cytokines affected and the level of inhibition was similar in LPS and anti-CD3/CD28 stimulated PBMCs derived from healthy volunteers and patients with SLE (Figure 1B). This evidence concerns the gene CD28 and systemic lupus erythematosus.